University of Leeds and Freeline Therapeutics Limited

Lead Participant: UNIVERSITY OF LEEDS

Abstract

To introduce advanced computational techniques and develop a new platform to accelerate discovery of novel and effective gene therapies to treat currently incurable diseases. To deliver new treatments faster and in a cost-effective manner.

Lead Participant

Project Cost

Grant Offer

UNIVERSITY OF LEEDS £327,348 £ 219,323
 

Participant

FREELINE THERAPEUTICS LIMITED
THE UNIVERSITY OF LEEDS

People

ORCID iD

Publications

10 25 50